Clinical Trials

15 enrolled

Genitourinary

Metastatic Castration-Resistant Prostate Cancer Patients

NCT00124527 2021-06-16

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

35 enrolled

Head & Neck

Thyroid Neoplasms

NCT00053365 2019-07-24

Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer

61 enrolled 10 charts

Carcinoma, Ovarian Epithelial

NCT00003441 2018-10-25

Irofulven in Treating Patients With Metastatic Colorectal Cancer

26 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003666 2016-07-20

Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer

36 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00124566 2016-01-18

Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

135 enrolled

Genitourinary

Prostatic Neoplasms

NCT00003786 2014-03-07

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 2 Withdrawn

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003390 2013-06-21

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00019552 2013-06-20

Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00005070 2013-06-19

Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Uterine Cervical Neoplasms

NCT00005968 2013-05-30

Irofulven in Treating Patients With Stage IV Melanoma

Dermatologic

Melanoma

NCT00005031 2013-05-27

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Endometrial Neoplasms

NCT00062257 2013-05-15

Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer

Stomach Neoplasms

NCT00003796 2013-02-11

Irofulven in Treating Patients With Metastatic Breast Cancer

32 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00003760 2012-08-09

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

3 enrolled